Navigation Links
Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
Date:6/16/2008

PITTSBURGH, June 16 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced that its subsidiary, Mylan Pharmaceuticals Inc., has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Venlafaxine Hydrochloride (HCl) Tablets 25 mg (base), 37.5 mg (base), 50 mg (base), 75 mg (base) and 100 mg (base).

Venlafaxine HCl Tablets, indicated for the treatment of major depressive disorder, are the generic version of Wyeth's Effexor(R) Tablets, which had annual U.S. sales of approximately $188 million for the 12 months ending March 31, 2008.

This product is shipping immediately. Currently, Mylan has 92 ANDAs pending FDA approval, 20 of which are potential first-to-file opportunities.

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3
...deceptively simple sugar is in fact a critical reg...ry reveals that, when disturbed, this process coul...g to properly control the steps and timing of cell...s say. The sugar, known as O-GlcNAc (pronounced o...
...d products that would help women protect themselve...S.// It can be developed in any form that is conve...tory. These microbicides will enable women to neg... who put them at risk and would also help avoid un...
... lipomatosis) is a rare, benign intra-articular le...mary benign tumour of the synovium, and forms part...ssive chronically swollen knee. About 50 cases of... reported, usually involving one knee, with occasi...
... and currently affects more that 18 million Americ...d for alternative diabetes therapies with earlier ...f insulin by the lung may provide an attractive al...s. However, alternative insulin delivery systems m...
Other Medicine News:Health News:Sugar Helps Control Cell Division 2Health News:Lipoma Arborescens: A Rare Tumor Of The Knee 2Health News:HIIP- A Novel Inhaled Insulin Delivery System As An Alternative To Injectable Insulin Therapy 2
(Date:9/5/2008)... HILLMAN, Mich., Sept. 5 /- When ...diagnosed in a whitetail deer at a deer farm in,Ke...lled the remaining deer,on the farmer,s property a...deer farm industry is issuing the following statem...f the herd at the Kent County Farm., The deer far...
(Date:9/5/2008)... VIENNA, Va., Sept. 5 /...y that it presented new rheumatoid arthritis data,...n Amsterdam. The data,presented by Dr. Daniel Zim...r Immunology of CEL-SCI, indicate that CEL-SCI,s r...etards the permanent tissue damage,caused by rheum...
(Date:9/5/2008)... The Study Demonstrates microRNAs Extracted From...s Effective Clinical Biomarkers for a Wide Range o...his Proprietary Technology, Rosetta Genomics is Cu...t to Detect Colon Cancer, REHOVOT, Israel and JER...tCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a ...
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstC...ay announced that the pivotal clinical study of,Po...,s partner, Chemische,Fabrik KREUSSLER & Co. GmbH ...dpoint and has been submitted to FDA as part of a ...al clinical study, named the EASI (Efficacy and sa...
Breaking Medicine Technology:Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 2Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference 264 1ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference 264 2Yakima Health Care Leader Tapped for Leadership Post at National Association 260 1Yakima Health Care Leader Tapped for Leadership Post at National Association 260 2Cepheid to Present at Thomas Weisel Partners Healthcare Conference 282 1Cepheid to Present at Thomas Weisel Partners Healthcare Conference 282 2Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference 278 1Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference 278 2
...oft, foam-lined FoamWrap ThumWrap Splints offer su...lints. Ideal to relieve mild pain or strain due to... Choose either the rigid or the flexible stay to p...and breathable, the ThumWrap Splint is comfortable...
...his lightweight orthosis is designed to comfortabl...ding the hand in a neutral position. It is fabrica...oplastic whose unique characteristics offer durabl...thosis provides rigid cast-like immobilization of ...
...he CTi Wrist Flex is a custom wrist orthotic desig...t specific to the patient's maximum range-of-motio...ist sprains with TFCC tear-triangular fibrocartila...Scaphoid nonunion , Partial tendon rupture , O...
Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
Medicine Products: